PMC:7441788 / 21282-21600
Annnotations
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T191","span":{"begin":302,"end":303},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T192","span":{"begin":314,"end":315},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"them were black; Despite adjustments to many possible confounding factors, there may still be undiscovered factors.\nRosenberg et al[60] Retrospective multicenter cohort study HCQ group:n = 271;HCQ +azithromycin group:n = 735control group:n = 221 HCQ:200 mg/400 mg/600 mg/other/unknown, frequency: once a day/twice a da"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T252","span":{"begin":198,"end":210},"obj":"Chemical"}],"attributes":[{"id":"A252","pred":"chebi_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"them were black; Despite adjustments to many possible confounding factors, there may still be undiscovered factors.\nRosenberg et al[60] Retrospective multicenter cohort study HCQ group:n = 271;HCQ +azithromycin group:n = 735control group:n = 221 HCQ:200 mg/400 mg/600 mg/other/unknown, frequency: once a day/twice a da"}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T142","span":{"begin":198,"end":210},"obj":"Chemical"}],"attributes":[{"id":"A142","pred":"chebi_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"them were black; Despite adjustments to many possible confounding factors, there may still be undiscovered factors.\nRosenberg et al[60] Retrospective multicenter cohort study HCQ group:n = 271;HCQ +azithromycin group:n = 735control group:n = 221 HCQ:200 mg/400 mg/600 mg/other/unknown, frequency: once a day/twice a da"}